Community Center

Amyloidosis is a localized or systemic disease caused by deposition of proteins in the extracellular space of various organs and tissues. As part of the disease,…

Amyloid fibrils, crystal-like fibrillar aggregates of denatured proteins, are formed linked with the breakdown of supersaturation, causing a series of amyloidosis…

PET/CT imaging with iodine-124 (I-124) evuzamitide may help monitor how patients with cardiac amyloidosis respond to therapy over time, according to a study…

Caring for complex clients can be both rewarding and challenging. This highlights the importance of a strong support network for providing the best possible…

There are nearly 20,000 proteins present throughout the body, but one protein, in particular, can cause problems when it accumulates in various areas of the body —…

1. Please would it be possible to tell us about Myeloma Patients EuropeMyeloma Patients Europe (MPE) is an umbrella organisation of myeloma and AL amyloidosis…

Systemic light chain (LC) amyloidosis (AL) is a disease where organs are damaged by an overload of a misfolded patient-specific antibody-derived LC, secreted by an…

This show will not be live streamed. You can submit your questions in advance by clicking the button "Notify when available." Learn about the latest in…

We conducted a retrospective population-based, matched cohort study using the National Health Insurance Research Database to estimate healthcare resource…

In this ARC TALKS webinar, ARC’s own Kristen Hsu presented the most current updates for the clinical trial landscape, with a focus on ATTR amyloidosis. Kristen will…